<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-15.9-a.7'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//edisonledger.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://edisonledger.com/business/form-8-5-ept-ri-kore-potash-plc/2026/06/01/</loc>
  <lastmod>2026-06-01T08:48:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Edison Ledger</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Form 8.5 (EPT/RI) - Kore Potash Plc</news:title>
   <news:publication_date>2026-06-01T08:48:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://edisonledger.com/business/form-8-5-ept-ri-alternative-income-reit-plc-2/2026/06/01/</loc>
  <lastmod>2026-06-01T08:46:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Edison Ledger</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Form 8.5 (EPT/RI) - Alternative Income REIT plc</news:title>
   <news:publication_date>2026-06-01T08:46:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://edisonledger.com/business/form-8-5-ept-ri-pphe-hotel-group-ltd/2026/06/01/</loc>
  <lastmod>2026-06-01T08:44:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Edison Ledger</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Form 8.5 (EPT/RI) - PPHE Hotel Group Ltd</news:title>
   <news:publication_date>2026-06-01T08:44:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://edisonledger.com/business/form-8-5-ept-ri-cab-payments-holdings-plc/2026/06/01/</loc>
  <lastmod>2026-06-01T08:42:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Edison Ledger</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Form 8.5 (EPT/RI) - CAB Payments Holdings Plc</news:title>
   <news:publication_date>2026-06-01T08:42:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://edisonledger.com/business/eightfold-ai-positioned-as-a-strategic-leader-in-the-2026-fosway-9-grid-for-talent-acquisition/2026/06/01/</loc>
  <lastmod>2026-06-01T08:00:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Edison Ledger</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Eightfold AI Positioned as a Strategic Leader in the 2026 Fosway 9-Grid™ for Talent Acquisition</news:title>
   <news:publication_date>2026-06-01T08:00:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://edisonledger.com/business/precede-biosciences-presents-new-asco-2026-data-demonstrating-ability-of-precede-bio-insight-to-decode-met-driven-biology-and-resistance-in-advanced-nsclc/2026/05/31/</loc>
  <lastmod>2026-05-31T14:00:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Edison Ledger</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Precede Biosciences Presents New ASCO 2026 Data Demonstrating Ability of Precede Bio Insight™ to Decode MET-Driven Biology and Resistance in Advanced NSCLC</news:title>
   <news:publication_date>2026-05-31T14:00:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://edisonledger.com/business/neuexcell-therapeutics-announces-encouraging-data-of-nxl-004-in-recurrent-malignant-glioma-at-2026-asco/2026/05/31/</loc>
  <lastmod>2026-05-31T10:00:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Edison Ledger</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>NeuExcell Therapeutics Announces Encouraging Data of NXL-004 in Recurrent Malignant Glioma at 2026 ASCO</news:title>
   <news:publication_date>2026-05-31T10:00:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://edisonledger.com/tech/jelly-tide-urgent-report-2026-the-shocking-rise-of-jellytide-gummies-what-consumers-need-to-know-about-the-viral-wellness-trend/2026/05/30/</loc>
  <lastmod>2026-05-30T13:55:00Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Edison Ledger</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>JELLY TIDE [URGENT REPORT 2026]: The Shocking Rise of JellyTide Gummies—What Consumers Need to Know About the Viral Wellness Trend</news:title>
   <news:publication_date>2026-05-30T13:55:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
